Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication
Overview
Authors
Affiliations
As the global eradication of poliomyelitis approaches the final stages, prompt detection of new outbreaks is critical to enable a fast and effective outbreak response. Surveillance relies on reporting of acute flaccid paralysis (AFP) cases and laboratory confirmation through isolation of poliovirus from stool. However, delayed sample collection and testing can delay outbreak detection. We investigated whether weekly testing for clusters of AFP by location and time, using the Kulldorff scan statistic, could provide an early warning for outbreaks in 20 countries. A mixed-effects regression model was used to predict background rates of nonpolio AFP at the district level. In Tajikistan and Congo, testing for AFP clusters would have resulted in an outbreak warning 39 and 11 days, respectively, before official confirmation of large outbreaks. This method has relatively high specificity and could be integrated into the current polio information system to support rapid outbreak response activities.
Polio outbreaks in the post-COVID-19 pandemic era: causes and solutions.
Alijanzadeh D, Karimi H, Masoumi N, Kazemzadeh K, Samieefar N, Mesdaghi M Pathog Glob Health. 2024; 119(1-2):60-72.
PMID: 39689254 PMC: 11905310. DOI: 10.1080/20477724.2024.2439740.
Gray E, Cooper L, Bandyopadhyay A, Blake I, Grassly N J Infect Dis. 2023; 228(1):80-88.
PMID: 36630295 PMC: 10304761. DOI: 10.1093/infdis/jiad004.
Enterovirus Surveillance (EVSurv) in Germany.
Keeren K, Bottcher S, Diedrich S Microorganisms. 2021; 9(10).
PMID: 34683328 PMC: 8538599. DOI: 10.3390/microorganisms9102005.
Molodecky N, Jafari H, Safdar R, Ahmed J, Mahamud A, Bandyopadhyay A Vaccine. 2021; 41 Suppl 1:A93-A104.
PMID: 34629206 PMC: 8463303. DOI: 10.1016/j.vaccine.2021.09.037.
Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies.
Voorman A, OReilly K, Lyons H, Goel A, Touray K, Okiror S Vaccine. 2021; 41 Suppl 1:A105-A112.
PMID: 34483024 PMC: 10109086. DOI: 10.1016/j.vaccine.2021.08.064.